FDA Kills ISO Voluntary Audit Program As MDSAP Efforts Accelerate
This article was originally published in The Gray Sheet
The agency has terminated a 2012-launched ISO 13485 voluntary audit program, which gave companies the chance for a one-year reprieve from an FDA inspection, to put all attention on the global Medical Device Single Audit Program.
You may also be interested in...
A mid-pilot program update from the Medical Device Single Audit Program shows the number of interested manufacturers spiked sharply in July, but is still a far cry from the end-of-2016 target of 330 participating companies. However, the pilot is meeting auditor recruitment and training goals.
After a long build up, four international regulatory authorities officially rolled out the Medical Device Single Audit Program pilot this month. Here are 10 things companies should know about the program.
Thirty manufacturers have used FDA’s ISO 13485 voluntary audit program since the two-year pilot began last June, freeing up scarce agency inspectional resources to be used elsewhere. However, it will likely be eventually absorbed by a pilot Medical Device Single Audit Program currently under development by the International Medical Device Regulators Forum.